Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laserscope (NASDAQ LSCP) -- Ignore unavailable to you. Want to Upgrade?

To: geoffrey Wren who wrote (252)	3/14/1999 1:06:00 AM
From: Dick Martin	Read Replies (1) \| Respond to of 314

It seems to me that the market for laser technology is very fragmented into lots of niches each with it own peculiarities. There are lots of companies with good technology chasing after sales in this area or that, but there really aren't killer applications as there is in the software business. It doesn't matter how smart management is or the technological prowess of the engineers if it all chases after a small market segment, it will be hard to gain sufficient volume to work a profit. The medical laser market is hard to sell into because hospitals are always challenged by funding and the business is competitive. LSCP is in a better position than many in the industry with a good marketing network and a good selection of viable products. Just have a look at Surgical Laser ( SLTI ) a company with excellent products and leading technology. The photodynamic therapy market is a good opportunity which is just beginning to open. It has taken approximately 25 years for it to come from research to market so maybe we shouldn't expect explosive growth here this year, but I think it is an important development as a cancer treatment which should fuel sustained growth to become a fairly large market in the years to come, but then again look for competition in this area too. Regards -- Dick Martin